INMED PHARMACEUTICALS INC. Inventory, Net of Allowances, Customer Advances and Progress Billings
INMED PHARMACEUTICALS INC. (INM) had Inventory, Net of Allowances, Customer Advances and Progress Billings of $186.75 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Inventory › Inventory, Net of Allowances, Customer Advances and Progress Billings
us-gaap:InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings · last filed 2023-11-14
- 2023-09-30: Inventory, Net of Allowances, Customer Advances and Progress Billings $186.75K.
- 2023-06-30: Inventory, Net of Allowances, Customer Advances and Progress Billings $93.82K.
| Period end | Inventory, Net of Allowances, Customer Advances and Progress Billings |
|---|---|
| 2023-09-30 | $186.75K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $93.82K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |